ESC Professional Premium Access

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease

Event: ESC Congress 2022
Topic: Thrombosis, Platelets, and Coagulation
Session type: Symposium
Date: 29 August 2022
Time: 16:30 - 17:30

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

5 presentations in this session

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease - Introduction.

Speaker: Professor D. Capodanno (Catania, IT)
Thumbnail

Short- and long-term efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: results of two network meta-analyses

Speaker: Professor E. Navarese (Bydgoszcz, PL)
Thumbnail

Clinical consensus statements on patients with acute coronary syndromes patients.

Speaker: Professor V. Kunadian (Newcastle-Upon-Tyne, GB)
Thumbnail

Clinical consensus statements on patients with chronic coronary syndromes.

Speaker: Professor P. Vranckx (Hasselt, BE)
Thumbnail

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease - Q&A and panel discussion.

Thumbnail

4 speakers from this session

Professor Davide Capodanno

University of Catania, Catania (Italy)
27 presentations
5 followers

Professor Eliano Pio Navarese

Nicolaus Copernicus University, Bydgoszcz (Poland)
3 presentations
0 follower

Professor Vijay Kunadian

Newcastle University, Newcastle-Upon-Tyne (United Kingdom of Great Britain & Northern Ireland)
10 presentations
1 follower

Professor Pascal Vranckx

Heart Centre Hasselt, Hasselt (Belgium)
22 presentations
0 follower

This platform is supported by

logo Novo Nordisk